biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Bioasis Connections

<< Previous

Bullboard Posts

Next >>

Comment by ronrydellon Jun 27, 2022 8:07am

175 Views

Post# 34783979

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Bioasis Connections

JD and Kayde wrote some great posts for this mornings consumption....I'm now informed about the flagship component X3b-001 and have some renewed faith in the company. A reasonable gamble. One must note that only those holding one million shares plus will have a reasonable chance of making some long term money....(ie 33K shares at, say, $10 per share on NASDAQ gives one only $333K dollars...discounted for inflation and time...doesn't amount to that much.

Just sayin' comments?

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec